Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
N Sehgal, A Gupta, RK Valli, SD Joshi… - Proceedings of the …, 2012 - National Acad Sciences
A 30-d course of oral administration of a semipurified extract of the root of Withania somnifera
consisting predominantly of withanolides and withanosides reversed behavioral deficits, …
consisting predominantly of withanolides and withanosides reversed behavioral deficits, …
[HTML][HTML] Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study
C Mucciarini, G Rossi, F Bertolini, R Valli, C Cirilli… - BMC cancer, 2007 - Springer
Background Although the diagnostic criteria and pathogenesis of gastrointestinal stromal
tumors (GIST) have recently been elucidated, knowledge of the epidemiology of this …
tumors (GIST) have recently been elucidated, knowledge of the epidemiology of this …
[HTML][HTML] Immunohistochemical biomarkers as a surrogate of molecular analysis in ovarian carcinomas: a review of the literature
G Santandrea, S Piana, R Valli, M Zanelli, E Gasparini… - Diagnostics, 2021 - mdpi.com
The term “ovarian carcinoma” encompasses at least five different malignant neoplasms: high-grade
serous carcinoma, low-grade serous carcinoma, endometrioid carcinoma, mucinous …
serous carcinoma, low-grade serous carcinoma, endometrioid carcinoma, mucinous …
Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1 …
…, U Saeed, M Mishra, RK Valli… - Journal of …, 2008 - Soc Neuroscience
Parkinson9s disease (PD) is a progressive neurodegenerative disease characterized by the
degeneration of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). …
degeneration of the dopaminergic neurons in the substantia nigra pars compacta (SNpc). …
Germinotropic lymphoproliferative disorder: A systematic review
…, M Zizzo, A Bisagni, E Froio, L De Marco, R Valli… - Annals of …, 2020 - Springer
Germinotropic lymphoproliferative disorder is a rare and rather enigmatic novel entity with
distinctive clinicopathological features, one of which is the typical co-infection by Human …
distinctive clinicopathological features, one of which is the typical co-infection by Human …
Making “asymmetric” partnerships work
T Minshall, L Mortara, R Valli… - Research-Technology …, 2010 - Taylor & Francis
… Robert Valli has had two decades of commercial experience as an investment banker
and … Some large firms refused to ente r discussions with start-ups unless there was some …
and … Some large firms refused to ente r discussions with start-ups unless there was some …
Resveratrol‐mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation
R Frazzi, R Valli, I Tamagnini, B Casali… - … journal of cancer, 2013 - Wiley Online Library
Resveratrol (RSV), a plant‐derived stilbene, induces cell death in Hodgkin lymphoma (HL)‐derived
L‐428 cells in a dose‐dependent manner (IC50 = 27 μM, trypan blue exclusion …
L‐428 cells in a dose‐dependent manner (IC50 = 27 μM, trypan blue exclusion …
[HTML][HTML] High variability of genomic instability and gene expression profiling in different HeLa clones
The HeLa cell line is one of the most popular cell lines in biomedical research, despite its
well-known chromosomal instability. We compared the genomic and transcriptomic profiles of …
well-known chromosomal instability. We compared the genomic and transcriptomic profiles of …
A randomized clinical trial comparing 22G and 25G needles in endoscopic ultrasound-guided fine-needle aspiration of solid lesions
…, F Decembrino, C Gallo, I Tamagnini, R Valli… - …, 2011 - thieme-connect.com
Results: A total of 129 solid lesions were randomized and data regarding 127 lesions were
analyzed. The mean number of passes was 3.7 (±1.9) in the 22G needle group and 3.8 (±2) …
analyzed. The mean number of passes was 3.7 (±1.9) in the 22G needle group and 3.8 (±2) …
[HTML][HTML] Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors
L Schirosi, N Nannini, D Nicoli, A Cavazza, R Valli… - Annals of oncology, 2012 - Elsevier
Background To analyze a multi-institutional series of type C thymic carcinomas (TCs) (including
neuroendocrine tumors), focusing on the expression and mutations of c-KIT. Materials …
neuroendocrine tumors), focusing on the expression and mutations of c-KIT. Materials …